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ABSTRACT 
Objective: The goal of this study was to research for an effective fraction on memory improvement of Korean red ginseng.  
Methods: In this study, 80 % ethanol red ginseng extract (RE) was divided into inner fluid (REUI) and outer fluid (REUO) by the ultrafiltration and then 
REUO was further separated into four fractions namely, REUO-00, REUO-30, REUO-50 and REUO-70, respectively, by Diaion HP-20 column chromatography.  
Results: REUO has protected more significantly the H2O2-induced SHSY-5Y cell death than REUI. Interestingly, the hydrophobic parts of the REUO 
(REUO-EtOHs) such as REUO-30,-50 and-70 decreased more significantly the H2O2-induced cell death than its hydrophilic part (REUO-00) in a dose-
dependent manner. Then, we focused on the activity of a candidate for cholinergic functions, because memory deficits of neurodegenerative diseases are 
closely associated with cholinergic dysfunctions. The REUO-EtOHs (1.25 mg/ml) inhibited the activity of the acetylcholinesterase and its half maximal 
inhibitory concentration (IC50) was about 2.358 mg/ml. Additionally, we investigated whether the intake of the REUO (50 mg/kg/d) during 12 w could 
improve memory impairment of 12-month old Tg2576 mice and decrease total soluble amyloid-β (Aβ) proteins in the mouse brain cortex. The REUO 
alleviated significantly the memory impairment and successfully reduced the levels of the soluble Aβ proteins in the mouse cortex.  
Conclusion: We finally suggest that the REUO, including majorly its hydrophobic part that may be considered as more effective for memory 
improvement, will be highly considered as valuable candidate for the memory-enhancing ingredients against cholinergic dysfunctions and cognitive 
impairments of neurodegenerative diseases including Alzheimer’s disease. 
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INTRODUCTION 
Alzheimer's disease (AD), the most common age-related 
neurodegenerative disorder, is characterized by the formation of senile 
plaques including amyloid-β (Aβ) peptides in the brains [1]. AD also 
manifests cognitive deficits and impairment of activities of daily living 
[2]. The cholinergic hypothesis states that the cholinergic dysfunction in 
the brain is related to the cognitive decline in the elderly and AD [3]. 
Inhibition of acetylcholinesterase (AChE) is currently taken as a primary 
therapeutic strategy for AD [4]. Although four AChE inhibitors have been 
currently approved for the treatment of AD, the drugs have produced 
undesirable side effects such as diarrhea, nausea, vomiting and 
bradycardia [1]. Therefore, a search for novel molecules from natural 
products has gained much attention by the researchers worldwide. As a 
result, a number of botanicals as memory enhancers have been tested 
for anticholinesterase activity [5]. 
Ginseng (Panax ginseng Meyer) is frequently used in Asian countries 
as a traditional herbal medicine. Many researchers have 
demonstrated various preventive effects of ginseng on memory 
impairment [6] and oxidative stress [7]. Especially, the improved 
cognition has been reported with the treatment of ginsenosides Rb1 
and Rg1 in animal models [8]. Despite the attractive features of 
ginsenosides as potential nutraceuticals for AD, their use has been 
limited for several reasons, including its high production cost and 
poor bioavailability [9]. 
In the course of the search for the effective fraction of the red 
ginseng as a functional food supplement with enhancing memory 
improvement and more safety applications, we found that an 
effective memory enhancing materials of Korean red ginseng might 
be not ginsenosides but an unidentified component. In this study, we 
investigated the inhibitory effects of ginsenoside included or not 
included fraction by ultrafiltration system and Diaion HP-20 column 
chromatography on the H2O2-induced cell death and checked 
whether a potential fraction could improve memory deficits of 
Tg2576 mice and decrease total soluble Aβ levels in the mouse brain 
cortex, compared with the AIE (extract of Artemisia iwayomogi).  
MATERIALS AND METHODS 
Materials 
The red ginseng (Panax ginseng C. A. Meyer) were purchased from local 
market namely, Geumsaninsam cooperative association (Geumsan, 
Korea). The ginseng specimen was deposited in the International 
Ginseng and Herb Research Institute (No.; GS201105). All other 
chemicals were of analytical grade and were purchased from Sigma.  
Extraction and fractionation 
Dried red ginseng was extracted with 500 ml of 80 % ethanol at 80 ℃ 
for 6 h using a round-bottom flask fitted with a cooling condenser. The 
obtained 80 % ethanol extract (RE) was concentrated and dried in vacuo. 
RE was dissolved with 1 l of water and then concentrated up to 20 % of 
extraction volume by ultrafiltration system with Hollow Fiber cartridge 
(pore size; 3 kDa, membrane area; 6 m2). The concentrated inner 
fraction (REUI) and the filtrated outer fraction (REUO) prepared by 
ultrafiltration system, were further dried in a freeze dryer. REUO was 
finally fractioned by Diaion HP-20 column chromatography using H2O, 
30 % EtOH, 50 % EtOH and 70 % EtOH in a sequential elution process, 
yielding four fractions namely of REUO-00, REUO-30, REUO-50, and 
REUO-70, respectively.  
Measurement of cell viability 
SH-SY5Y cells were seeded in a 96 well plate at a density of 7 x 103 
cells/well. The collected fractions (50 µg/ml) and DHED (50 µM) were 
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introduced into the media for 4 h before treatment with H2O2 (750 
µM). Cell viability was determined using WST-1 metabolizing activity 
according to the manufacturer’s instruction (Roche, Indianapolis, IN, 
USA). The absorbance of the reaction product was finally measured 
with an ELISA reader (Bio-Rad, Munich, Germany) at a wavelength of 
450 nm.  
Acetylcholinesterase assay 
The acetylcholinesterase (AChE) assay was carried out by the 
colorimetric method using acetylthiocholine iodide as a substrate [10]. 
Absorbance was measured at 410 nm immediately after adding 100 µl of 
enzymes to the reaction mixtures. Reading was repeated at 30 s intervals 
for 5 min. AChE activity was calculated using absorption coefficient 1.36 
l/mmol/min. The half maximal inhibitory concentration (IC50) of the 
sample was calculated from a linear estimate of the enzyme inhibition 
dose response curve. 
Animals 
Tg2576 mice were purchased from Taconic Laboratories that over-
express a mutated form of the human amyloidal precursor protein 
(APP) 695 [11]. All experiments were carried out in accordance with 
the Guidelines for Animal Experiments of Ethics Committee of Seoul 
National University in Korea. The outer fraction of the ultrafiltrated 
red ginseng extract (REUO, 50 mg/kg) or the Artemisia iwayomogi 
extract (AIE, 50 mg/kg) mixed with the standard laboratory chow, 
was administered to the 9 mo old mice for 12 w. Food intake and 
mouse weight were recorded weekly at proper manner.  
Passive avoidance test 
A step-through type passive avoidance test apparatus (Model PACS-
30, Columbus Instruments Int., USA) was used to evaluate the effects 
of the REUO or the AIE on learning and memory, essentially as 
described by Shen et al. [12]. 
Collection of brain tissues and western blot 
After the behavioral test, mice were terminated at 13 mo old age. 
The brains were removed from the skull and the brains were further 
used for molecular works. The protein concentrations were 
quantified using Bio-Rad Protein Assay Reagent (Bio-Rad, USA). Brain 
tissues were homogenized with 10 volumes of homogenization buffer 
(12.5 mM sodium phosphate pH 7.0, 400 mM NaCl) and centrifuged at 
1,000g for 10 min. After adding homogenization buffer containing 0.5 
% Triton X-100 to the supernatant, the mixtures were continuously 
stirred for 30 min and centrifuged again at 10,000g for 10 min. Protein 
was resolved in 16.5 % tris/glycine gel, electrophoresed at 30~50 mg 
of protein/lane, and transferred onto a nitrocellulose membrane 
(Amersham Pharmacia, Buckinghamshire, UK). The protein blot was 
confirmed with 6E10 primary antibody for total soluble Aβ peptide 
and detected using horseradish peroxidase-conjugated secondary 
antibody (Amersham Pharmacia, Buckinghamshire, UK). 
Immunoreactive bands were visualized using an ECL enhanced 
chemiluminescence system (ECL; Amersham Pharmacia, 
Buckinghamshire, UK). The protein loading control was checked with 
GAPDH antibody. 
High-performance liquid chromatography (HPLC) analysis of 
ginsenoside 
Ten mg of ginseng extract or fraction was melted by 1 ml of 
methanol (MeOH) and filtered out by 0.45 μm membrane filter after 
extraction of ultrasonic waves for 2 h, then analyzed in HPLC. The 
HPLC system was Waters 1525 (Waters, USA) with PDA detector 
(Water, 2998). Waters XbridgeTM C18 column (250 mm × 4.6 mm, 5 
μm, Waters, USA) was also used. The detection wavelength, flow 
rate, injection volume, and column oven temperature were set at 
203 nm, 1.0 ml/min, 20 μl, and 40℃, respectively. The mobile phase 
consisted of purified water (A) and acetonitrile (B) using the 
following gradient program: 0 min 18 % B, 0-42 min 24 % B, 42-46 
min 29 % B, 46-75 min 40 % B, 75-100 min 65 % B, 100-135 min 85 
% B, and 135-180 min 18 % B. 
Statistical analysis 
Data were expressed as mean±SE (standard error of mean). One-
way ANOVA followed by Dunnett’s post hoc test (SPSS version 21) 
was applied to study the relationship between the different 
variables. p<0.05 was considered to be significant.  
RESULTS AND DISCUSSION 
Ginsenoside content in red ginseng extracts and each fraction 
As shown in table 1, the contents of ginsenoside, including 
protopanaxadiol (PPD) type ginsenoside such as Rb1, Rb2, Rb3, Rc, Rd, 
Rg3, Rk1, and Rg5 and protopanaxatriol (PPT) type ginsenoside such as 
Rg1, Re, Rf and F1, were measured separately in RE, REUI, REUO, and 
REUO-30. The total ginsenosides contents of RE, REUI, and REUO were 
24.57, 106.94, and 10.74 mg/g, respectively. The total ginsenosides in 
REUI of an inner fluid fraction after ultrafiltration, was about 4.4 and 
9.9 times higher than those of RE of ginseng extract and REUO of an 
outer fluid fraction of ginseng extract. The main ginsenoside of REUO 
was PPT-type ginsenosides such as Rg1, Re, and Rf, while REUI 
contained PPD-type ginsenosides such as Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rk1, 
and Rg5, more hydrophobic ginsenosides than PPT-type ginsenoside. 
The ratio of Rb1 to Rg1 (Rb1/Rg1) and PPD-to PPT-type ginsenoside 
(PPD/PPT) of RE, REUI, and REUO were found to be 1.77 and 1.75, 
15.90 and 11.22, and 0.23 and 0.13, respectively. Generally, 
ultrafiltration is a technique for separating dissolved molecules in 
solution on the basis of a size which means that molecules larger than 
the membrane pore size rating will be retained at the surface of the 
membrane [14]. The molecular weight of ginsenoside was below 
1,110, even though the molecular weight of PPD-type ginsenoside was 
slightly larger than those of PPT-type ginsenoside. The ginsenoside 
molecular size is smaller than pore size of membrane filters used for 
these experiments. Nevertheless, relatively hydrophobic PPD-type 
ginsenosides in RE did not pass through the hydrophilic membrane 
with 3 kDa pore size [14]. Only relatively hydrophilic PPT-type 
ginsenosides, Re and Rg1 slowly passed through the membrane in 
continuous solution flow system. So, REUO included PPT-type 
ginsenosides and smaller dissolved micromolecules, passed through 
the membranes. However, any ginsenoside was not detected in the 
REUO-30 fraction by Diaion HP-20 column chromatography from 
REUO.  
Some subfractions of the red ginseng extract decrease 
cytotoxicity induced by H2O2 
The red ginseng extracted by 80 % ethanol was divided into the 
inner fraction (REUI) and the outer fraction (REUO) by the 
ultrafiltration membrane. Dehydroevodiamine (DHED) was used as 
a positive control. Exposure of SHSY-5Y neuroblastoma to H2O2 (750 
µM) during 24 h, induced significant neurotoxicity compared to 
control (p<0.01, fig. 1). DHED or each fraction of the red ginseng 
extract was pretreated to cells for 4 h before H2O2 treatment. Both 
DHED (50 µM) and REUO (50 µg/ml) treatment decreased more 
significantly the H2O2-induced cell death than the vehicle and the 
REUI (50 µg/ml) treatment compared to the control (fig. 1A). 
Ginsenoside content of REUI was about 10.7 %, while its content of 
REUO was about 1.1 % (table 1). These results revealed that the 
inhibitory effect of H2O2-induced cell death was due to an 
unidentified component of REUO but not ginsenosides of REUI. In 
order to find out neuroprotective ginseng component, REUO was 
further separated into several different fractions such as, REUO-00, 
REUO-30, REUO-50 and REUO-70, by Diaion HP-20 column 
chromatography using H2O, 30 % EtOH, 50 % EtOH and 70 % EtOH 
in a sequential elution process, respectively. The hydrophilic 
fraction of REUO-00 eluted with H2O included the hydrophilic 
component such as sugar. Any ginsenosides were not detected in 
REUO-30 eluted with 30 % EtOH (table 1). The hydrophobic 
fractions (50 µg/ml) of the REUO (REUO-EtOHs) such as REUO-30, 
REUO-50, and REUO-70 also declined more significantly the H2O2-
induced cell death than the vehicle and the hydrophilic fractions (50 
µg/ml) of the REUO such as REUO-00 (fig. 1B). Therefore, REUO-
EtOHs including REUO-30, REUO-50 and REUO-70 fractions, were 
collected in order to compare with the red ginseng extract (RE) 
along with its ultrafiltrated outer fraction (REUO). As shown in fig. 
1C, the REUO-EtOHs (50 µg/ml) decreased more significantly the 
H2O2-induced cell death than the RE (50 µg/ml) and the REUO (50 
µg/ml). Additionally, REUO-EtOHs has also inhibited the H2O2-
induced cell death significantly in a dose-dependent manner (fig. 
1D).  
The subfractions of the red ginseng extract inhibit AChE activity 
Amyloid-β (Aβ) represents the underlying cause of the cognitive 
deficits observed in AD, leading to cell death through the induction 
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of oxidative stress [15]. Therefore, memory-enhancing foods on 
memory are considered to be effective for cholinergic functions [16]. 
The characteristic roles of Aβ on cholinergic function reported 
recently that AChE activity was increased more around amyloid 
plaque [17]and vulnerable cholinergic neuronal loss in AD was 
closely related to inhibition of high-affinity choline uptake and ACh 
release by Aβ [18]. Owing to the cholinergic hypothesis, strategies 
for increasing synaptic levels of ACh have been widely explored in 
the development of anti-dementia drugs [19]. To test a cholinergic 
action, the acetylcholinesterase (AChE) activity assay was carried 
out. DHED and the Artemisia iwayomogi extract (AIE) were used as 
the positive controls. The inhibitory percentage of 37.8 µM DHED, 
the 0.5 mg/ml AIE and 1.5 mg/ml REUO-EtOHs were noted as % of 
inhibition (fig. 1E). The REUO-EtOHs inhibited more significantly the 
AChE-induced activity than 250 µM Rb1, 250 µM Rg1, 1.25 mg/ml RE 
and 1.25 mg/ml REUO, respectively. The REUO-EtOHs also inhibited 
the AChE activity in a dose-dependent manner (fig. 1F). The 
concentration required for 50 % enzyme inhibition (IC50) was found to 
be 2.358 mg/ml. In this study, we also demonstrated that some 
candidates including REUO blocked the AChE activities, and the REUO 
inhibited the AChE activity in a dose-dependent manner. It indicates 
that those plant extracts might contain an efficient unidentified 
anticholinesterase component. Because the REUO is a crude extract, its 
inhibitory activity (IC50=2.358 mg/ml) could not be compared to that 
of known single compounds, such as donepezil [20] and DHED [21]. 
Among the possible strategies aimed at increasing cholinergic 
neurotransmission, the AChE inhibitor would be valuable candidates 
and easily accessible therapeutic agent for maintaining ACh levels in 
the brain as well as improving cognitive ability [22]. 
The ultra filtered outer fraction of the red ginseng extract 
improves the memory impairment and decreases the levels of 
total soluble Aβ peptides in Tg2576 mice 
To investigate whether the impairments of learning and memory in 
Tg2576 mice could be improved by the intake of the REUO, the 
passive avoidance test was carried out. 
  
 
Fig. 1: Effects of the sub fractions of the red ginseng extract on cytotoxicity induced by H2O2 (750 µM). A) The H2O2-induced cell death was 
inhibited by the 50 µg/ml REUO but did not by the 50 µg/ml REUI in SH-SY5Y cells. The level of the REUO is similar with the level of the 
positive control (50 µM DHED-treated cells). B) The H2O2-induced cell death was decreased by the 50 µg/ml REUO-30, 50 µg/ml REUO-50, and 
50 µg/ml REUO-70 but did not by 50 µg/ml REUO-00 in the SH-SY5Y cell, respectively. The levels of the REUO-30, REUO-50 and REUO-70, are 
similar with the level of the DHED-treated cells. C) The H2O2-induced cell death was prevented by the 50 µg/ml REUO and the 50 µg/ml REUO-
EtOHs but did not by the 50 µg/ml RE in SH-SY5Y cells. The levels of the REUO-EtOHs were more effective than that of the REUO in the 
inhibition of the H2O2-induced cell death. D) The REUO-EtOHs prevented the H2O2-induced cell death as a dose-dependent manner. #p<0.05 
compared with the control, **p<0.01 compared with the H2O2-treated control, and †p<0.05 compared between two samples linked by the line 
in one-way ANOVA with a post hoc Dunnett’s test. Each value represents the mean±SE. E) The AChE activity was inhibited by 37.8 µM DHED, 
the 0.5 mg/ml AIE, the 1.25 mg/ml REUO, and the 1.25 mg/ml REUO-EtOHs but did not by 250 µM Rg1, 250 µM Rb1 and the 1.25 mg/ml RE. F) 
The concentration required for 50 % enzyme inhibition (IC50) was 2.358 mg/ml. The inhibitory efficacy was expressed as the percentage of 
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Fig. 2: Effects of the ultrafiltrated outer fraction of the red ginseng extract on memory impairment total Aβ levels in Tg2576 mouse brains. In 12 
mo-old Tg2576 (Tg) and wild-type (Wt) mice, the passive avoidance test was performed after intake of the REUO (50 mg/kg) or the AIE (50 
mg/kg) for 12 w. A) Note that latency was decreased significantly in the vehicle-treated Tg2576 mice compared to the vehicle-treated and the 
REUO-treated wild-type mice. However, the short latency time was increased significantly by the REUO intake compared to non-treatment in the 
Tg2576 mice. B) Each representative blot of total soluble Aβ peptides or GAPDH was shown. C) The production of total soluble Aβ peptides was 
highly increased in the cortex of the vehicle-treated Tg2576 mice compared with the vehicle-treated and the REUO-treated wild-type mice. Note 
that the high levels of total soluble Aβ in the vehicle-treated Tg2576 mice was decreased by the intake of the REUO. Data represents mean±SE. 
*p<0.05 and #p<0.05 compared with the vehicle-treated wild-type mice and the vehicle-treated Tg2576 mice, respectively, one-way ANOVA with 
a post hoc Dunnett’s test (n=5~9) 
The AIE (50 mg/kg) or the REUO (50 mg/kg) mixed with the 
standard laboratory chow was administrated to 9 mo-old Tg2576 
and wild-type mice during 12 w. As shown in fig. 2A, the latency of 
the non-treated Tg2576 mice (37.86±20.53 s) was more shortened 
than that of non-treated (202.70±42.57 s, p = 0.004) and the REUO-
treated (217.56±42.99 s, p = 0.004) wild-type mice. Interestingly, 
the latency of the non-treated Tg2576 mice was more increased 
than that of the REUO-treated Tg2576 mice (177.83±40.35 s, p = 
0.012). 
However, the AIE compared with REUO did not improve the memory 
impairment of Tg2576 mice. After completing the behavioral test, 
neurochemical changes in the brain were analyzed to investigate the 
inhibitory effect of the REUO on the Aβ production after repeated 
intake of the REUO (50 mg/kg) mixed with the standard laboratory 
chow to Tg2576 mice for 12 w. The AIE (50 mg/kg) or the REUO (50 
mg/kg) mixed with the standard laboratory chow was administrated 
to 9 mo-old Tg2576 and wild-type mice during 12 w. As shown in fig. 
2A, the latency of the non-treated Tg2576 mice (37.86±20.53 s) was 
more shortened than that of non-treated (202.70±42.57 s, p = 0.004) 
and the REUO-treated (217.56±42.99 s, p = 0.004) wild-type mice. 
Interestingly, the latency of the non-treated Tg2576 mice was more 
increased than that of the REUO-treated Tg2576 mice 
(177.83±40.35 s, p = 0.012). However, the AIE compared with REUO 
did not improve the memory impairment of Tg2576 mice. After 
completing the behavioral test, neurochemical changes in the brain 
were analyzed to investigate the inhibitory effect of the REUO on the 
Aβ production after repeated intake of the REUO (50 mg/kg) mixed 
with the standard laboratory chow to Tg2576 mice for 12 w. 
Levels of total Aβ peptides in the brains of the mice were shown in 
the fig. 2B and 2C. Levels of total soluble Aβ peptides were increased 
more in vehicle-treated Tg2576 mice than the vehicle-treated or the 
REUO-treated wild-type mice. Interestingly, increasing levels of total 
soluble Aβ peptides was traumatically reduced by the repeated 
intake of the REUO, but did not shown by the repeated intake of the 
AIE. The brain is particularly susceptible to oxidative stress because 
of its high oxygen consumption, high polyunsaturated fatty acid 
content and low antioxidant defences [23].  
Numerous studies have demonstrated that generation of reactive 
oxygen species [24] and inhibition of choline uptake [18] plays a 
crucial role in the pathogenesis of AD. In Tg2576 mice, the REUO 
could improve memory deficits and decrease the levels of total Aβ 
proteins in the mouse brains. In the discussion, further purification 
to isolate one or more bioactive components from the red ginseng 
and further analysis on their structure and effects should be carried 
out for a better understanding of its pharmacologic mechanisms. 
Although the action mechanisms of plant extract that have been 
used medicinally and traditionally need to be investigated. 
Furthermore, it is thought that the outer fraction of the ultra 
filtrated red ginseng extracts, especially non-saponin fractions of red 
ginseng, may be considered as cognition-enhancing food 
supplements that protect cholinergic dysfunction, oxidative stress, 
and Aβ production
Pyo et al. 
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Table 1: The contents of ginsenosides in ginseng extract and fractions 
Ginsenoside (mg/g) RE REUI REUO REUO-30 
PPT type     
Rg1 3.52  2.22  4.49  N. D. 
Re 3.49  2.71  4.13  N. D. 
Rf 1.64  1.81  0.90  N. D. 
F1 0.29  2.02  N. D. N. D. 
Subtotal 8.93  8.75  9.52   
PPD type     
Rb1 6.21  35.31  1.03  N. D. 
Rc 5.04  26.91  0.19  N. D. 
Rb2 2.60  16.67  N. D. N. D. 
Rd 0.68  7.38  N. D. N. D. 
S-Rg3 0.35  1.67  N. D. N. D. 
R-Rg3 0.22  4.11  N. D. N. D. 
Rk1 0.19  2.45  N. D. N. D. 
Rg5 0.34  3.68  N. D. N. D. 
Subtotal 15.64  98.19  1.22   
Total 24.57  106.94  10.74   
PPD/PPT 1.75  11.22  0.13   
Rb1/Rg1 1.77  15.90  0.23   
RE, Red ginseng extract with 80 % ethanol; REUI, the inner fraction of red ginseng extract concentrated up to 20 % of extraction volume by 
ultrafiltration system with Hollow Fiber cartridge (pore size; 3 kDa); REUO, the filtrated outer fraction of red ginseng extract prepared by 
ultrafiltration system; REUO-30, the eluting fraction with 30 % ethanol of REUO fractioned by Diaion HP-20 column chromatography using H2O, 30 
% EtOH, 50 % EtOH and 70 % EtOH in a sequential elution process; PPT, protopanaxatriol; PPD, protopanaxadiol; N. D., not detected. 
 
CONCLUSION 
We conclude that the outer fraction of the ultra filtrated red ginseng 
extract, including the majority of its hydrophobic part, may be more 
effective for memory improvement, will be strongly considered as a 
novel candidate for the memory-enhancing ingredients against 
cholinergic dysfunctions and cognitive impairments of neuro-
degenerative diseases including Alzheimer’s disease. However, we 
remained further purification and identification of smaller unknown 
component with memory improvement effect of Korean red ginseng. 
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